Transfusion-related bacterial sepsis

Current Opinion in Hematology

Volumn 4, Issue 6, 1997, Pages 464-469

  Wagner, Stephen ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; THROMBOCYTE CONCENTRATE;

BACTEREMIA; BACTERIUM CONTAMINATION; BLOOD COMPONENT; BLOOD CULTURE; BLOOD STORAGE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CELL SUSPENSION; CONTAINER; CRYOPRESERVATION; ERYTHROCYTE; ERYTHROCYTE CONCENTRATE; HUMAN; HYGIENE; LEUKAPHERESIS; NONHUMAN; PRIORITY JOURNAL; SCREENING TEST; SEPSIS; SHORT SURVEY; SKIN DECONTAMINATION; TEMPERATURE; THROMBOCYTE;

EID: 0030732730     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199704060-00019     Document Type: Short Survey

References (40)

1. Krishnan LAG, Brecher ME: Transfusion-transmitted bacterial infection. Hematol Oncol Clin North Am 1995, 9:167-185.
2. Barrett BB, Andersen JW, Anderson KC: Strategies for the avoidance of bacterial contamination of blood components. Transfusion 1993, 33:228-234.
3. Soeterboek AM, Welle FHW, Jansz A, van der Loop CMF: Prevalence of bacterial contamination in whole blood after donation. Vox Sang 1995, 69:149.
4. Leiby DA, Kerr KL, Campos JM, Dodd RY: A retrospective analysis of microbial contaminants in outdated random-donor platelets from multiple sites. Transfusion 1997, 37:259-263.
5. Soeterboek AM, Welle FH, Marcelis JH, van der Loop CM: Sterility testing of blood products in 1994/1995 by three cooperating blood banks in The Netherlands. Vox Sang 1997, 72:61-62.
6. Goldman M, Blajchman MA: Blood product-associated bacterial sepsis. Transfus Med Rev 1991, 5:73-83.
7. Padley D, Koontz F, Trigg ME, Gingrich R, Strauss RG: Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations. Transfusion 1996, 36:53-56.
8. Attarian H, Bensinger WI, Buckner CD, McDonald DL, Rowley SD: Microbial contamination of peripheral blood stem cell collections. Bone Marrow Transplant 1996, 17:699-702.
9. Cohen A, Tepperberg M, Waters-Pick B, Coniglio D, Perfect J, Peters WP, Gilbert C, Morgan C, Vredenburgh JJ: The significance of microbial cultures of the hematopoietic support for patients receiving high-dose chemotherapy. J Hematother 1996, 5:289-294.
10. Webb IJ, Coral FS, Andersen JW, Elias AD, Finberg RW, Nadler LM, Ritz • J, Anderson KC: Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering. Transfusion 1996, 36:782-788. The most thorough paper in this series of six publications [7-12] characterizing the bacterial contamination of hematopoietic progenitor preparations. It is some-what unusual that the authors found no positive cultures from 291 bone marrow preparations (before the advent of cryopreservation, no complex processing).
11. Espinosa MTF, Fox R, Creger RJ, Lazarus HM: Microbiologic contamination of peripheral blood progenitor cells collected from hematopoietic cell transplantation. Transfusion 1996, 36:789-793.
12. Jestice HK, Farrington M, Hunt C, Matthews I, Scott MA, Foreman J, Marcus RE: Bacterial contamination of peripheral blood progenitor cells for transplantation. Transfus Med 1996, 6:103-110.
13. McDonald CP, Barbara JAJ, Hewitt P, Hartley S, Telfer P, Gale R, James E, Prentice HG: Yersina enterocolitica transmission from a red cell unit 34 days old. Transfus Med 1996, 6:61-63.
14. Haverly RM, Harrison CR, Dougherty TH: Yersinia enterocolitica bacteremia associated with red blood cell transfusion. Arch Pathol Lab Med 1996, 120:499-500.
15. Schwalbe B, Kneitinger E, Marre R, Kubanek B, Gottfied HW, Georgieff M: Fatal Yersinia sepsis after intraoperative transfusion. Anästhesiol Intensivmed Notfallmed Schmerzther 1996, 31:658-660.
16. Woernle CH, Hoffman RE, Smith JD, Osterholm MT, Thompson RE, Sewell CM, Halpin TJ, Istre GR, Hutcheson R: Update: Yersinia enterocolitica bacteremia and endotoxin shock associated with red blood cell transfusions: United States 1991. MMWR 1991, 40:176-178.
17. Goldman M, Long A, Roy G, Decary F: Incidence of positive bacterial cultures after donor call-back. Transfusion 1996, 1035.
18. Goldman M, Roy G, Fréchette, Décary F, Massicotte L, Delage G: Evaluation of donor skin disinfection methods. Transfusion 1997, 37:309-312.
19. Högman CF, Fritz H, Sandberg L: Posttransfusion Serratia marcescens septicemia. Transfusion 1993, 33:189-191.
20. Heltberg O, Skov F, Gerner-Smidt P, Kolmos HJ, Dybkjaer E, Gutschik E, Jerne D, Jepsen OB, Weischer M, Frederiksen W, Sorensen H: Nosocomial epidemic of Serratia marcescens septicemia ascribed to contaminated blood transfusion bags. Transfusion 1993, 33:221-227.
21. AuBuchon JP, Pickard C, Herschel L: Sterility of plastic tubing welds in components stored at room temperature. Transfusion 1995, 35:303-307.
22. Dzik W: Use of leukodepletion filters for the removal of bacteria. Immunol Invest 1995, 24:95-115.
23. Wagner SJ, Robinette D, Dodd R: Factors affecting Yersinia enterocolitica (serotype 0:8) viability in deliberately inoculated blood. Transfusion 1993, 33:713-716.
24. Visser LG, Annema A, Van Furth R: Role of Yops inhibition of phagocytosis and killing of opsonized Yersinia enterocolitica by human granulocytes. Infect Immun 1995, 63:2570-2575.
25. Ruckdeschel K, Roggenkamp A, Schubert S, Heesemann J: Differential • contribution of Yersinia enterocolitica virulence factors to evasion of microbicidal action of neutrophils. Infect Immun 1996, 64:724-733. An elegant microbiologic investigation of the molecular biology of Y. enterocolitica plasmid-encoded virulence genes.
26. Portnoy DA, Moseley SL, Falkow S: Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis. Infect Immun 1981, 31:775-782.
27. Heesemann J, Keller C, Morawa R, Schmidt N, Siemens HJ, Laufs R: Plasmids of human strains of Yersinia enterocolitica: molecular relatedness and possible importance for pathogenesis. J Infect Dis 1983, 147:107-115.
28. Stack G, Baril L, Napychank P, Snyder EL: Cytokine generation in stored, white cell-reduced, and bacterially contaminated units of red cells. Transfusion 1995, 35:199-203.
29. Connor J, Currie LM, Allan H, Livesey SA: Recovery of in vitro functional activity of platelet concentrates stored at 4°C and treated with second-messenger effectors. Transfusion 1996, 36:691-698.
30. Currie LM, Harper JR, Allan H, Connor J: Inhibition of cytokine accumulation and bacterial growth during storage of platelet concentrates at 4°C with retention of in vitro functional activity. Transfusion 1997, 37:18-24.
31. Wagner SJ, Robinette D, Nazario M, Moroff G: Bacteria levels in components prepared from deliberately inoculated whole blood held for 8 or 24 hours at 20-24°C. Transfusion 1995, 35:911-916.
32. Sanz C, Pereira A, Vila J, Faundez A-I, Gomez J, Ordinas A: Growth of bacteria in platelet concentrates obtained from whole blood stored for 16 hours at 22°C before component preparation. Transfusion 1997, 37:251-254.
33. Reik H, Rubin SJ: Evaluation of the buffy coat smear for rapid detection of bacteremia. JAMA 1981, 245:357-359.
34. McCarthy LR, Senne JE: Evaluation of acridine orange stain for detection of microorganisms in blood cultures. J Clin Microbiol 1980, 11:281-285.
35. Brecher ME, Boothe G, Kerr A: The use of a chemiluminescence-linked universal bacterial ribosomal RNA gene probe and blood gas analysis for the rapid detection of bacterial contamination in white cell-reduced and nonreduced platelets. Transfusion 1993, 33:450-457.
36. Burstain JM, Brecher ME, Workman K, Foster M, Faber GH, Mair D: Rapid identification of bacterially contaminated platelets using reagent strips: glucose and pH analysis as markers of bacterial metabolism. Transfusion 1997, 37:255-258.
37. Wagner SJ, Robinette D: Evaluation of swirling, pH, and glucose tests for the detection of bacterial contamination in platelet concentrates. Transfusion 1996, 36:989-993.
38. Blajchman MA: Bacterial contamination of blood products and the value of pre-transfusion testing. Immunol Invest 1995, 24:163-170.
39. Chiu EK, Yuen KY, Lie AK, Liang R, Lau YL, Lee AC, Kwong YL, Wong S, Ng MH, Chan TK: A prospective study of symptomatic bacteremia following platelet transfusion and of its management. Transfusion 1994, 34:950-954.
40. Lin L, Cook DN, Wiesehahn GP, Alfonso R, Behrman B, Cimino GD, Corten L, Damonte PB, Dikeman R, Dupuis K, et al.: Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997, 37:423-435. This is an outstanding contribution from a large group of investigators studying a novel psoralen, currently in clinical trials, for inactivation of viruses and bacteria in platelet components. It contains an extensive survey of in vitro platelet properties after photoinactivation and includes a limited study of the survival of rhesus monkey platelets after phototreatment.